К. Yu. Nikolaev
Новосибирский государственный университет
- Lipoproteins and Cardiovascular Health
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Imaging and Diagnostics
- Diabetes Treatment and Management
- Cardiovascular Disease and Adiposity
Чем занимается
Ключевые темы по публикациям: Lipoproteins and Cardiovascular Health; Antiplatelet Therapy and Cardiovascular Diseases; Cardiac Imaging and Diagnostics; Diabetes Treatment and Management; Cardiovascular Disease and Adiposity.
Последние работы
Все 92 в OpenAlex- Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial2022
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis2022 · аннотациясвернуть
OBJECTIVE: Finerenone reduced the risk of kidney and cardiovascular events in people with chronic kidney disease (CKD) and type 2 diabetes in the FIDELIO-DKD and FIGARO-DKD phase 3 studies. Effects of finerenone on…
Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol2021 · аннотациясвернуть
BACKGROUND: Guidelines recommend nonstatin lipid-lowering agents in patients at very high risk for major adverse cardiovascular events (MACE) if low-density lipoprotein cholesterol (LDL-C) remains ≥70 mg/dL on maximum…
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes2023 · аннотациясвернуть
BACKGROUND: In patients with chronic kidney disease (CKD) and type 2 diabetes (T2D), finerenone, a nonsteroidal mineralocorticoid receptor antagonist, reduces cardiovascular and kidney failure outcomes. Finerenone also…
- Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment2021
- Machine Learning Models Integrating CYP2C19 Genotypes for Long-Term Risk Prediction and Personalized Antiplatelet Therapy Selection in Myocardial Infarction2026
- Clinical and diagnostic significance of heart fatty acid-binding protein (H-FABP) in cardiological practice2026
- Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES2025
Наукометрия
Написать научруку
Email не найден в открытых источниках — поищи на странице вуза или в последних статьях.
Шаблон письма
Здравствуйте, К. Yu. Nikolaev! Я студент(ка) [курс, факультет, вуз]. Мне интересна тема [опишите интересы своими словами]. Прочитал(а) вашу работу «Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial» (2022) — она близка к тому, чем я хочу заниматься. Хочу обсудить возможность выполнить научную работу под вашим руководством. Буду благодарен(на) за ответ — готов(а) рассказать о себе подробнее и прислать резюме. С уважением, [Имя Фамилия]
На этапе теста письмо отправляешь сам из своей почты. Отправка из сервиса и статусы заявок — скоро.